To strengthen the evidence that the ferroptosis-related pathway could be a therapeutic target for FSHD, we tested the effect of Fer-1 on DUX4-Tg mice in vivo (Figure 11A). Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.